Unequal test timing creates the apparent harm from meal timing after tissue replacement
Measurement and interpretationIn tissue-replacement studies, apparent meal-timing harm reflects when testing occurs relative to biological rhythms and feeding.
Full text
PHENOMENON DOESN'T EXIST: The apparent reversal of meal-timing benefit is produced by testing at unequal biological phases and unequal intervals since the last meal. Fixed-clock performance tests capture temporary fasting or sleep-related troughs, while sparse tissue samples misclassify phase. A subsequent alignment intervention moves testing into a favorable interval and appears to rescue recovery. There is no replacement-specific deterioration in phase-balanced recovery or independent function.
A prespecified replacement-status × meal-timing × measured-tissue-phase interaction is equivalent to zero within a clinically justified margin when function is sampled across the daily cycle and recovery challenges are balanced for biological phase and time since feeding.
Full text
The original fixed-clock apparent harm remains reproducible, but integrated daily performance and sustained recovery do not worsen. A persistent functional deficit with a mechanism-specific rescue falsifies this hypothesis.
Under matched nutrition, drug concentrations, and tissue metabolic flux, donor–host phase alignment increases donor-reactive cytotoxicity and prolongs functional recovery in allogeneic replacements; a At fixed intestinal delivery and measured tissue phases, worsening recovery follows increased graft glucose uptake paired with reduced retained-tissue uptake during low hepatic output.
Full text
Redistributing
The harmful schedule reduces oral labeled-peptide appearance and net protein incorporation, without a corresponding defect after intravenous delivery. A matched systemic amino-acid exposure profile ab
With parent-drug concentration profiles, absorbed nutrients, and tissue phases matched, harmful meal timing increases microbial-metabolite exposure, hepatic glutathione depletion, and drug-derived pro